Magnetic mesoporous silica nanospheres (MMSN) were prepared and the surface was modified with cancer cell-specific ligand folic acid. Calcium carbonate was then employed as acid-activated gatekeepers to cap the mesopores of the MMSN, namely, MMSN-FA-CaCO3. The formation of the MMSN-FA-CaCO3 was proved by several characterization techniques, viz. transmission electron microscopy, zeta potential measurement, Fourier transform infrared spectroscopy, BET surface area measurement, and UV–Vis spectroscopy. Daunomycin was successfully loaded in the MMSN-FA-CaCO3 and the system exhibited sensitive pH stimuli-responsive release characteristics under blood or tumor microenvironment. Cellular uptake by folate receptor (FR)-overexpressing HeLa cells of the MMSN-FA-CaCO3 was higher than that by non-folated-conjugated ones. Intracellular-uptake studies revealed preferential uptake of these nanoparticles into FR-positive [FR(+)] HeLa than FR-negative [FR(-)]A549 cell lines. DAPI stain experiment showed high apoptotic rate of MMSN-FA-DNM-CaCO3 to HeLa cells. The present data suggest that the CaCO3 coating and folic acid modification of MMSN are able to create a targeted, pH-sensitive template for drug delivery system with application in cancer therapy.
ChanMH andLinHM.Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking. Biomaterials2015;
46: 149–158.
2.
EwerMS andEwerSM.Cardiotoxicity of anticancer treatments. Nat Rev Cardiol2015;
12: 547–558.
3.
PradosJMelguizoCOrtizRet al.
Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anticancer Agents Med Chem2012;
12: 1058–1070.
4.
WuHLiuGZhangSet al.
Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands. J Mater Chem2011;
21: 3037–3045.
5.
ZhangCLiCHuangSet al.
Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery. Biomaterials2010;
31: 3374–3383.
6.
WagnerE.Programmed drug delivery: nanosystems for tumor targeting. Expert Opin Biol Ther2007;
7: 587–593.
7.
WeitmanSDLarkRHConeyLRet al.
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res1992;
52: 3396–3401.
8.
CampbellIGJonesTAFoulkesWDet al.
Folate-binding protein is a marker for ovarian cancer. Cancer Res1991;
51: 5329–5338.
9.
StellaBArpiccoSPeracchiaMTet al.
Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci2000;
89: 1452–1464.
10.
BaeYJangWDNishiyamaNet al.
Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol BioSyst2005;
1: 242–250.
11.
KamalyNKalberTThanouMet al.
Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. Bioconjugate Chem2009;
20: 648–655.
12.
PrabaharanMGrailerJJPillaSet al.
Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Biomaterials2009;
30: 3009–3019.
13.
RuizhernándezEBaezaA andValletregíM.Smart drug delivery through DNA/magnetic nanoparticle gates. Acs Nano2011;
5: 1259–1266.
14.
ChenXYaoXWangCet al.
Mesoporous silica nanoparticles capped with fluorescence-conjugated cyclodextrin for pH-activated controlled drug delivery and imaging. Meso Mater2015;
217: 46–53.
KatoYOzawaSMiyamotoCet al.
Acidic extracellular microenvironment and cancer. Cancer Cell Int2013;
13: 89–97.
17.
DanhierFFeronO andPréatV.To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release2010;
148: 135–146.
18.
HonglawanANiHWeissmanDet al.
Synthesis of random copolymer based pH-responsive nanoparticles as drug carriers for cancer therapeutics. Polym Chem2013;
4: 3667–3675.
19.
IslamKNBakarMZBANoordinMMet al.
Characterisation of calcium carbonate and its polymorphs from cockle shells (Anadara granosa).Powder Technol2011;
213: 188–191.
20.
MellmanIFuchsR andHeleniusA.Acidification of the endocytic and exocytic pathways. Annu Rev Biochem1986;
55: 663–700.
21.
MoreiraAFGasparVMCostaECet al.
Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery. J Corrial Eur J Pharm Biopharm2014;
88: 1012–1025.
22.
LiuMCJinSFZhengMet al.
Daunomycin-loaded superparamagnetic iron oxide nanoparticles: preparation, magnetic targeting, cell cytotoxicity, and protein delivery research. J Biomater Appl2016;
31: 261–272.
23.
KimJLeeJELeeJet al.
Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc2006;
128: 688–689.
24.
ChangBShaXGuoJet al.
Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem2011;
21: 9239–9247.
25.
ZhaoXJiaXLiuLet al.
Double-crosslinked hyaluronic acid nanoparticles with pH/reduction dual-responsive triggered release and pH-modulated fluorescence for folate receptor-mediated targeting visualized chemotherapy. Biomacromolecules2016;
17: 1496–1505.
26.
DingW andLinG.Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery. Int J Nanomedicine2013;
8: 4631–4638.
27.
ZhangHLiFYiJet al.
Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery. Eur J Pharm Sci2011;
42: 517–526.
28.
ZhaoPLiuMCMadanayakeTWet al.
Cationic porphyrin@SPION nanospheres as multifunctional anticancer therapeutics: magnetic targeting, photodynamic potential and bio-safety research. Rsc Adv2016;
6: 103137–103148.
29.
GuoMQueCWangCet al.
Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. Biomaterials2011;
32: 185–194.
30.
SahooBDeviKSPBanerjeeRet al.
Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug. ACS Appl Mater Interfaces2013;
5: 3884–3893.
31.
SahooBDeviKSPDuttaSet al.
Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications. J Colloid Interface Sci2014;
431: 31–41.
32.
ChoiKM andKurodaK.Polymorph control of calcium carbonate on the surface of mesoporous silica. Cryst Growth Des2012;
12: 887–893.
33.
WangYLiBZhangLet al.
Multifunctional magnetic mesoporous silica nanocomposites with improved sensing performance and effective removal ability toward Hg(II). Langmuir2012;
28: 1657–1662.
34.
RosenholmJMSahlgrenC andLindénM.Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles – opportunities & challenges. Nanoscale2010;
2: 1870–1883.
35.
ZhaoXZhaoHYuanHet al.
Multifunctional superparamagnetic Fe3O4@SiO2 core/shell nanoparticles: design and application for cell imaging. J Biomed Nanotechnol2014;
10: 262–270.
36.
ZhuYFangY andKaskelS.Folate-conjugated Fe3O4@SiO2 hollow mesoporous spheres for targeted anticancer drug delivery. J Phys Chem C2010;
114: 16382–16388.
37.
YangCGuoWCuiLet al.
Fe3O4@mSiO2 core-shell nanocomposite capped with disulfide gatekeepers for enzyme-sensitive controlled release of anti-cancer drug. J Mater Chem B2015;
3: 1010–1019.
38.
YangCGuoWCuiLet al.
pH-responsive magnetic core-shell nanocomposites for drug delivery. Langmuir2014;
30: 9819–9827.
39.
DoughtyBRaoYKazerSWet al.
Binding of the anti-cancer drug daunomycin to DNA probed by second harmonic generation. J Phys Chem B2013;
117: 15285–15289.
40.
LiuRQinPWangLet al.
Toxic effects of ethanol on bovine serum albumin. J Biochem Mol Toxicol2010;
24: 66–71.
